Labeling and Promotional Materials. All Licensed Product packages will comply with all patent marking requirements as specified in 35 USC Sec. 287.
Labeling and Promotional Materials. Subject to applicable laws and regulations, labeling on all Products and Services sold by or on behalf of Xxxxxxx, its Affiliates, or Sublicensees pursuant to this Agreement and on all package inserts will identify Biogen Idec as licensor of the Biogen Idec Patents and will comply with all patent marking requirements as specified in 35 USC § 287. *** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Labeling and Promotional Materials. XXXXXX-XXXXXXX shall have sole authority and responsibility to seek and/or obtain any necessary Governmental or Regulatory Authority approvals of any label, labeling, package inserts, Product monographs and packaging, and Promotional Materials used in connection with the Products, and for determining whether the same requires Governmental or Regulatory Authority approval. No Product label, labeling or Promotional Materials may be used or distributed by PFIZER unless such label, labeling or Promotional Materials have been approved in advance by the Country Marketing Team and, for purposes of determining compliance with applicable Laws, XXXXXX- XXXXXXX, pursuant to XXXXXX-XXXXXXX'x internal procedures.
Labeling and Promotional Materials. Subject to applicable laws and regulations, packaging for all Products sold by or on behalf of Licensee, its Affiliates, or Sublicensees pursuant to this Agreement and on all package inserts and labeling will identify SDP (or its successor assign) as licensor of the ADVENTRX Patents and will comply with all patent marking requirements as specified in 35 USC Sec. 287 or other applicable patent marking requirements of other jurisdictions to preserve and maximize the rights and remedies of SDP and ADVENTRX.
Labeling and Promotional Materials. On and following the Marketed Products Closing:
Labeling and Promotional Materials. Notwithstanding the provisions of Section 8.03 of the Agreement, Pfizer shall have authority and responsibility to seek and/or obtain any necessary Governmental or Regulatory Authority approvals of any label, labeling, package inserts, Product monographs and Packaging, on Promotional Materials used in connection with the Products, and for determining whether the same requires Governmental or Regulatory Authority approval; provided, however, that no such labels, labeling, package inserts, Product monographs and packaging, and Promotional Materials may used or distributed by Pfizer unless the same shall be approved in advance by the China Country Marketing Team and, for the purposes of determining compliance with applicable laws, Xxxxxx-Xxxxxxx, pursuant to Xxxxxx- Xxxxxxx'x internal procedures.
Labeling and Promotional Materials. (a) Pfizer and its Affiliates shall have the sole authority and responsibility to seek and/or obtain any necessary FDA approvals of any label, labeling, package inserts and packaging used in connection with the Product, and for determining whether the same requires FDA approval.
Labeling and Promotional Materials. On and following the Marketed Products Closing: *** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. UCYCLYD / HYPERION ASSET PURCHASE AGREEMENT AMENDED AND RESTATED COLLABORATION AGREEMENT
Labeling and Promotional Materials. ViroPharma shall be solely responsible for obtaining any approval from a Regulatory Authority of any label, labeling, package inserts, packaging, and Promotional Materials used in connection with VP Product, and for determining whether the same requires approval from a Regulatory Authority. ViroPharma shall use commercially reasonable efforts to establish and maintain the resources to perform its duties under this Section 7.3. As permitted by applicable Laws, ViroPharma and Aventis shall be given equal exposure and prominence on all VP Product labels, labeling, package inserts, packaging, and Promotional Materials used or distributed in connection with VP Product under this Agreement; except that either Party may request that its name not be used, to the extent permitted by applicable Laws. As permitted by applicable Laws, the Parties shall attempt to have the appearance of VP Product labels, labeling, package inserts, packaging, and Promotional Materials used or distributed in connection with VP Product under this Agreement conform with the guidelines and requirements of each Party. Each package or label of VP Product shall bear the statement "Under license from SANOFI-SYNTHELABO", or such other statement that SaSy may reasonably request, including, without limitation, references to patent numbers, provided that such wording otherwise complies with all Laws applicable to such labeling. ViroPharma shall use commercially reasonable efforts to ensure that any markings requested by SaSy to appear on the label or packaging of VP Products are reasonable, and are consistent with the decisions made by the MSC or the JSC regarding such packaging or labeling.
Labeling and Promotional Materials
